HM97662 / Hanmi  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
HM97662 / Hanmi
NCT05598151: Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors

Recruiting
1
140
RoW
HM97662
Hanmi Pharmaceutical Company Limited
Advanced or Metastatic Solid Tumors
02/25
06/28

Download Options